Concepedia

Márk Barok

MB

Statistics

Publications

14

Citations

1.3K

H-Index

12

Active since

2007

Affiliations

Tampere University Hospital(Current)

University of Debrecen

Hungarian Academy of Sciences

University of Helsinki

Márk Barok is an author at Tampere University Hospital specializing in tumor biology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2007–2025

14

Publications

14

Trastuzumab causes antibody-dependent cellular cytotoxicity–mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance

Márk Barok, Jorma Isola, Zsuzsanna Pályi‐Krekk et al. · Molecular Cancer Therapeutics · 2007 · 235 citations · Full text

Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo

Márk Barok, Minna Tanner, Katri Köninki et al. · Breast Cancer Research · 2011 · 230 citations · Full text

Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer

Márk Barok, Minna Tanner, Katri Köninki et al. · Cancer Letters · 2011 · 154 citations

, , +10

Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer

Zsuzsanna Pályi‐Krekk, Márk Barok, Jorma Isola et al. · European Journal of Cancer · 2007 · 143 citations · Full text

, , +9

Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells

Katri Köninki, Márk Barok, Minna Tanner et al. · Cancer Letters · 2010 · 107 citations

, , +7

1–5 of 14